Cerebral FURIN deficiency impairs astrocytic lipophagy through ITGAV maturation.
Study Design
- Study Type
- Other
- Population
- cerebral FURIN-deficient mice
- Intervention
- Cerebral FURIN deficiency impairs astrocytic lipophagy through ITGAV maturation. None
- Comparator
- None
- Primary Outcome
- astrocytic lipophagy and cognitive function
- Effect Direction
- Negative
- Risk of Bias
- Unclear
Abstract
FURIN cleaves a subset of proproteins into functional mature fragments. Evidence suggests that FURIN is involved in brain development and the associated diseases, whereas the potential mechanisms remain incompletely understood. Here, we report that cerebral FURIN-deficient mice exhibit cognitive decline and neurodegeneration. Lipid droplets (LDs) that are preferentially accumulated in astrocytes correlate with an increase of the LD markers PLIN2 and PLIN3, and conversely a decreased level of autophagic proteins including ATG5, BECN1 and MAP1LC3/LC3 as well as LAMP1. Accordingly, silencing of Furin in astrocytic cells impairs lipophagic flux with alterations in lipid metabolites. We then demonstrate that cytosolic ITGAV (integrin alpha V) is a principal substrate of FURIN. An ITGAV mutant that prevents FURIN-mediated maturation diminishes lysosomal puncta and lipophagic processing, in which a translational mechanism contributes to the reduction of autophagic proteins. We finally show that the mature but not mutant ITGAV rescues LD accumulation in FURIN-defective cells. Collectively, these data highlight the fact that ITGAV maturation is a key event in astrocytic lipophagy regulation which is involved in neurodegeneration of FURIN-deficient mice.Abbreviations: ACTB: actin, beta; AD: Alzheimer disease; ADAM10: a disintegrin and metallopeptidase domain 10; ADGGA: acyl diacylglyceryl glucuronide; AHexSIS: acylhexosyl sitosterol; AHexSTS: acylhexosyl stigmasterol; AIF1/IBA1: allograft inflammatory factor 1; APP: amyloid beta precursor protein; ATG5: autophagy related 5; Aβ: amyloid β-protein; BACE1: beta-site APP cleaving enzyme 1; BASulfate: bile acid sulfate; BMP: bismonoacylglycerophosphate; CAR: acylcarnitine; CE: cholesteryl ester; Cer_NS: ceramide non-hydroxyfatty acid-sphingosine; CL: cardiolipin; CMA: chaperone-mediated autophagy; DAPI: 4',6-diamidino-2-phenylindole; DCAE: esterified deoxycholic acid; DEP: differentially expressed protein; DG: diacylglycerol; DGCC: diacylglyceryl-3-O-carboxyhydroxymethylcholine; DLG4/PSD95: discs large MAGUK scaffold protein 4; ECM: extracellular matrix; EtherLPC: ether-linked lysophosphatidylcholine; EtherLPE: ether-linked lysophosphatidylethanolamine; EtherMGDG: ether-linked monogalactosyldiacylglycerol; EtherOxPC: ether-linked oxidized phosphatidylcholine; EtherPC: ether-linked phosphatidylcholine; EtherPE: ether-linked phosphatidylethanolamine; EtherPG: ether-linked phosphatidylglycerol; EtherSMGDG: semino lipid; EtherTG: ether-linked triacylglycerol; FA: fatty acyls; FA: free fatty acid; FAHFA: fatty acid ester of hydroxyl fatty acid; FJC: fluoro-Jade C; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GDCAE: esterified glycodeoxycholic acid; GFAP: glial fibrillary acidic protein; GL: glycerolipids; GP: glycerophospholipids; HBMP: hemibismonoacylglycerophosphate; HexCer_NS: hexosylceramide non-hydroxyfatty acid-sphingosine; HSPA8/HSC70: heat shock protein 8; IP-MS: immunoprecipitation-mass spectrometry; KEGG: Kyoto Encyclopedia of Genes and Genomes; LAMP1: lysosomal-associated membrane protein 1; LAMP2A: lysosomal-associated membrane protein 2A; LDGCC: lysodiacylglyceryl-3-O-carboxyhydroxymethylcholine; LDs: lipid droplets; LNAPE: N-acyl-lysophosphatidylethanolamine; LNAPS: N-acyl-lysophosphatidylserine; LPA: lysophosphatidic acid; LPC: lyso-phophatidylcholine; LPE: lysophosphatidylethanolamine; LPG: lysophosphatidylglycerol; LPI: lysophosphatidylinositol; LPS: lysophosphatidylserine; MAP1LC3B/LC3B: microtubule-associated protein 1 light chain 3 beta; MGDG: monogalactosyldiacylglycerol; MWM: Morris Water Maze; OA: oleic acid; OFT: Open Field Test; OxPC: oxidized phosphatidylcholine; OxPG: oxidized phosphatidylglycerol; OxPI: oxidized phosphatidylinositol; OxPS: oxidized phosphatidylserine; PC: phosphatidylcholine; PE: phosphatidylethanolamine; PE_Cer: ceramide phosphoethanolamine; PG: phosphatidylglycerol; PI: phosphatidylinositol; PLIN2: perilipin 2; PLIN3: perilipin 3; PMeOH: phosphatidylmethanol; PPI: protein-protein interaction; PS: phosphatidylserine; PSEN1/PS1: presenilin 1; RBFOX3/NeuN: RNA binding protein fox-1 homolog (C. elegans) 3; SHexCer: sulfatide; SL: sulfonolipid; SM: sphingomyelin; SP: sphingolipids; ST: sterol lipids; TDCAE: esterified taurodeoxycholic acid; TG: triacylglycerol; TLCAE: esterified taurolithocholic acid; TUNEL: terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling.
TL;DR
It is shown that the mature but not mutant ITGAV rescues LD accumulation in FURIN-defective cells, highlighting the fact that ITGAV maturation is a key event in astrocytic lipophagy regulation which is involved in neurodegeneration of FURIN-deficient mice.
Used In Evidence Reviews
Similar Papers
Cellular and molecular life sciences : CMLS · 2005
Surface exposure of phosphatidylserine in pathological cells.
Molecular medicine (Cambridge, Mass.) · 2011
Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease.
Cell · 1983
Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site?
Journal of Alzheimer's disease : JAD · 2012
Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease.
Current opinion in hematology · 2000
Oxidation and erythrocyte senescence.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2006